The deal will move Illumina “deeper into the application of its gene-sequencing technology to the diagnosis and treatment of patients."
The deal is J&J's biggest move into surgical robotics, which "has been a gap for its medical device business."
Analysts warn Bayer could face a "litigious headache" after the $289 million jury award in a product liability case over Monsanto's Roundup pesticide.
